Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
about
Nicotine receptor partial agonists for alcohol dependenceNicotine receptor partial agonists for alcohol dependenceAlcohol and nicotine interactions: pre-clinical models of dependenceMedications for unhealthy alcohol use: across the spectrum.A Genetic Animal Model of Alcoholism for Screening Medications to Treat Addiction.Nicotinic receptor modulation to treat alcohol and drug dependenceMicroRNAs in NeurotoxicityAnimal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validityCHRNA5 and CHRNA3 variants and level of neuroticism in young adult Mexican American men and women.Varenicline decreases ethanol intake and increases dopamine release via neuronal nicotinic acetylcholine receptors in the nucleus accumbens.Nicotine infusion in the wake-promoting basal forebrain enhances alcohol-induced activation of nucleus accumbens.Partial agonists of the α3β4* neuronal nicotinic acetylcholine receptor reduce ethanol consumption and seeking in rats.Effects of varenicline on ethanol-induced conditioned place preference, locomotor stimulation, and sensitization.Varenicline, a partial agonist at neuronal nicotinic acetylcholine receptors, reduces nicotine-induced increases in 20% ethanol operant self-administration in Sprague-Dawley rats.The role of varenicline on alcohol-primed self-administration and seeking behavior in ratsNicotinic Mechanisms Modulate Ethanol Withdrawal and Modify Time Course and Symptoms Severity of Simultaneous Withdrawal from Alcohol and Nicotine.Oral delivery of ivermectin using a fast dissolving oral film: Implications for repurposing ivermectin as a pharmacotherapy for alcohol use disorder.Positive and negative effects of alcohol and nicotine and their interactions: a mechanistic review.Neuronal nicotinic acetylcholine receptors: neuroplastic changes underlying alcohol and nicotine addictionsCritical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.Accentuating effects of nicotine on ethanol response in mice with high genetic predisposition to ethanol-induced locomotor stimulationRecent Advances in Nicotinic Receptor Signaling in Alcohol Abuse and Alcoholism.Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening.The CHRNA5/A3/B4 gene cluster and tobacco, alcohol, cannabis, inhalants and other substance use initiation: replication and new findings using mixture analyses.Introduction to the special issue "Pharmacotherapies for the treatment of alcohol abuse and dependence" and a summary of patents targeting other neurotransmitter systems.The effects of varenicline on alcohol seeking and self-administration in baboons.The α5 neuronal nicotinic acetylcholine receptor subunit plays an important role in the sedative effects of ethanol but does not modulate consumption in mice.Pharmacological approaches to reducing craving in patients with alcohol use disorders.Nicotine administration in the cholinergic basal forebrain increases alcohol consumption in C57BL/6J mice.Varenicline and neuronal nicotinic acetylcholine receptors: a new approach to the treatment of co-occurring alcohol and nicotine addiction?Interactions between nicotine and drugs of abuse: a review of preclinical findings.The nicotine + alcohol interoceptive drug state: contribution of the components and effects of varenicline in ratsVarenicline decreases nicotine but not alcohol self-administration in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats.Effect of Varenicline Combined With Medical Management on Alcohol Use Disorder With Comorbid Cigarette Smoking: A Randomized Clinical Trial.The nicotinic receptor drug sazetidine-A reduces alcohol consumption in mice without affecting concurrent nicotine consumption.Mecamylamine treatment for alcohol dependence: a randomized controlled trial.Nicotine administration in the wake-promoting basal forebrain attenuates sleep-promoting effects of alcohol.Pilot investigation: randomized-controlled analog trial for alcohol and tobacco smoking co-addiction using contingency management.Differential regulation of alcohol taking and seeking by antagonism at α4β2 and α3β4 nAChRs.
P2860
Q24234860-CE965203-4549-4D69-ABDA-026E7AE66FABQ26472086-9C18856B-0530-4DE8-AE93-BBC483C61333Q27345275-0262A11D-A04B-41B7-B1A1-A9871A402372Q27690692-C408B6EE-C487-4778-8FCE-B86B4133365DQ28068256-4A8FC673-7D5B-4C0B-94D2-5B5DB25A4429Q28087047-6D24CA42-BF7B-4FCA-AD68-68187F11FF83Q28382954-E9E2B6C2-DFAE-40F5-B670-19B63D2A7EEFQ30447847-8BD9D99B-B558-41ED-899C-A4521515CAF4Q33668283-7CBD9A56-DAF0-4365-BD4D-16DC8F085179Q33929766-7C1A1A87-E3E7-48D3-B2E3-977297650583Q34415917-31950D6A-1900-43CF-AAB4-5D2D9CD12D33Q34661812-6E9A66D7-4E33-4D19-AAB0-6A246E64A13DQ34940888-F23D6484-C2B8-4E6F-9909-0ED97D1123D8Q35046256-A46EE77E-DEE5-4185-B234-CC583A036876Q35788371-69AE440F-C235-4141-AA88-FE5FD071084DQ35960331-2859611E-6AEF-4F67-AB1F-70E22B56D348Q36011376-14785B59-4C25-459F-AACB-1BE6B868F25CQ36039402-5DEC1282-BA45-42EB-8724-8B0C6D7AA6F9Q36137598-D3195076-5781-4D5E-8C36-9288BFED06C4Q36372867-D60103FB-6BEC-41E1-9D5E-80476E8AA185Q36420087-F1DB27E8-A606-4A9D-B970-7AACA7333E0BQ36581617-BCDADEB8-DA71-42C3-A281-E964FB6104FBQ36581622-13D1AF06-FEE5-43FB-B22C-9FFA39767665Q37094759-D59857A9-20A7-420E-AD6C-71B7AEEDA0F7Q37404222-C5B65579-9898-404A-A9FB-C82D9AB0A4CBQ37404736-1EF81A77-C948-43DF-8EA1-30B8EA63D5D2Q37514878-AFF4D0D0-0A2C-4B49-96F3-674B379C221BQ37708082-C522F2EB-E862-4B4C-A55D-47ACD03E70F2Q37722622-704ABEAB-1391-47A7-9CF4-970405FB259FQ38129470-2AB529A4-94E3-4CC2-9B05-56C9470A4528Q38824915-C538391D-44E6-4887-B5B8-97153013DA92Q41566428-12DFBA90-3376-4C70-A5B7-AFC9715C16FEQ43188062-8D0BC152-8FFD-4FDA-8755-E3C7CFB5DA6EQ47275723-5D966ED8-D77C-4835-B015-EF5D8515027DQ47550611-4ED91AB3-BA4D-428E-94ED-0818DC28B62DQ47667884-168B433C-43D6-4B69-B806-733454724369Q47960292-5A1E1A3F-A9AB-4B6A-9B83-BE2501D2017DQ52316684-96B768EF-787C-4D42-A864-8703D6DC3728Q52639267-7A534252-F6B4-41E5-96A8-0E4F82D0C8C0
P2860
Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuronal nicotinic acetylcholi ...... ment of alcohol use disorders.
@en
Neuronal nicotinic acetylcholi ...... ment of alcohol use disorders.
@nl
type
label
Neuronal nicotinic acetylcholi ...... ment of alcohol use disorders.
@en
Neuronal nicotinic acetylcholi ...... ment of alcohol use disorders.
@nl
prefLabel
Neuronal nicotinic acetylcholi ...... ment of alcohol use disorders.
@en
Neuronal nicotinic acetylcholi ...... ment of alcohol use disorders.
@nl
P2860
P1476
Neuronal nicotinic acetylcholi ...... ment of alcohol use disorders.
@en
P2093
S Chatterjee
S E Bartlett
P2860
P356
10.2174/187152710790966597
P577
2010-03-01T00:00:00Z